$56.99
A dual-peptide formulation combining a modified GHRH(1-29) analog (CJC-1295 without DAC) with the selective GHS-R agonist Ipamorelin, designed to study synergistic somatotroph activation and pulsatile GH release.
This compound ships 1-2 weeks of order placement. Reserve yours now - stock is allocated on a first-come, first-served basis.
Add $47.01 more to hit the $100 threshold.
Tracked delivery
Every order
Available
Molecular weight
Formula
Shipping note
on orders over $100